|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL ARTICLE |
in Wilms tumour: gene alterations and immunoexpression
1 Department of Pathology, University of Chicago, Chicago, Illinois, USA
2 Department of Hematology and Oncology, University of Chicago
3 Department of Health Studies, University of Chicago
4 Department of Pediatrics, University of Chicago
5 Van Andel Research Institute, Grand Rapids, Michigan, USA
6 Department of Pathology, Northwestern Memorial Hospital, Northwestern University, Feinberg School of Medicine, Chicago
Correspondence to:
X J Yang
Department of Pathology, Feinberg 7-334, Northwestern Memorial Hospital, Northwestern University, Feinberg School of Medicine, 251 E Huron Street, Chicago, IL 60611,USA; xyang{at}northwestern.edu
Background: Topoisomerase II
(topoII
) is an essential enzyme gene in regulating DNA structure and cell proliferation and is encoded by the TOP2A. Using cDNA microarray analysis, TOP2A has been reported to be one of the top genes overexpressed in Wilms tumour.
Aim: To evaluate the role of TopoII
in Wilms tumorigenesis and its prognostic value.
Methods: TOP2A gene copy numbers were determined using the fluorescence in situ hybridisation technique, and protein expression levels of TopoII
by immunostaining in 39 samples of primary and 18 samples of metastatic Wilms tumour.
Results: TOP2A gene amplification was detected only in anaplastic Wilms tumours, and none of the Wilms tumours showed deletion of the TOP2A gene. TopoII
protein overexpression was detected in 97% of Wilms tumours, and correlated strongly with proliferation, as measured by Ki-67 (r = 0.85). The high TopoII
expression was associated with the presence of vascular invasion, prominent apoptosis, metastases and adverse clinical outcomes (p<0.05).
Conclusions: Our findings suggest that TopoII
overexpression in Wilms tumours is caused by a change at the transcription level, except for anaplastic Wilms tumours, in which gene amplification was present. High levels of TopoII
protein are correlated with tumour aggressiveness. The assessment of TopoII
expression in Wilms tumour may have prognostic value.
Abbreviations: FISH, fluorescence in situ hybridisation; IHC, immunohistochemistry; PFS, progression-free survival; TMA, tissue microarray; topoII
, topoisomerase II
This article has been cited by other articles:
![]() |
E. J. Kort, L. Farber, M. Tretiakova, D. Petillo, K. A. Furge, X. J. Yang, A. Cornelius, and B. T. Teh The E2F3-Oncomir-1 Axis Is Activated in Wilms' Tumor Cancer Res., June 1, 2008; 68(11): 4034 - 4038. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Dougherty, A. Sehdev, S. Cerda, R. Mustafi, N. Little, W. Yuan, S. Jagadeeswaran, A. Chumsangsri, J. Delgado, M. Tretiakova, et al. Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model Clin. Cancer Res., April 15, 2008; 14(8): 2253 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Stewenius, Y. Jin, I. Ora, J. de Kraker, J. Bras, A. Frigyesi, J. Alumets, B. Sandstedt, A. K. Meeker, and D. Gisselsson Defective Chromosome Segregation and Telomere Dysfunction in Aggressive Wilms' Tumors Clin. Cancer Res., November 15, 2007; 13(22): 6593 - 6602. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |